Published in JAMA on March 05, 1997
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax (2012) 4.06
Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax (2013) 3.62
Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med (2006) 1.88
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol (2009) 1.40
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol (2007) 1.13
Systemic effects of inhaled corticosteroids: an overview. Open Respir Med J (2014) 0.97
Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax (2004) 0.97
Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology. Respir Res (2011) 0.96
Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci (2012) 0.95
Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. Ann Rheum Dis (2013) 0.90
Use of inhaled corticosteroids following discharge from an emergency department for an acute exacerbation of asthma. Thorax (2004) 0.86
Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. Br J Clin Pharmacol (2014) 0.84
Safety of inhaled corticosteroids in the treatment of persistent asthma. J Natl Med Assoc (2006) 0.83
Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model. Biotechnol Bioeng (2015) 0.82
Fortnightly review: modern drug treatment of chronic asthma. BMJ (1999) 0.82
VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice. PLoS One (2013) 0.81
Inhaled corticosteroids and the risk of diabetes among the elderly. Br J Clin Pharmacol (2002) 0.80
Inhaled Corticosteroids. Pharmaceuticals (Basel) (2010) 0.79
THE PARADOXICAL EFFECT ON PNEUMONIA OF CHRONIC INHALED CORTICOSTEROIDS. Clin Pulm Med (2013) 0.78
Risk of adverse gastrointestinal events from inhaled corticosteroids. Pharmacotherapy (2008) 0.77
Ocular side effects of anti-rheumatic medications: what a rheumatologist should know. Lupus (2010) 0.76
Randomized trial of acupoints herbal patching in Sanfu Days for asthma in clinical remission stage. Clin Transl Med (2016) 0.75
Glucocorticoid use and risks of ocular hypertension and glaucoma. JAMA (1997) 0.75
Effects of inhaled fluticasone on intraocular pressure and central corneal thickness in asthmatic children without a family history of glaucoma. Middle East Afr J Ophthalmol (2012) 0.75
The effect of long-term use of intranasal steroids on intraocular pressure. Clin Ophthalmol (2016) 0.75
Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats. Vet Ophthalmol (2016) 0.75
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Increased risk of open-angle glaucoma following chronic rhinosinusitis: a population-based matched-cohort study. Eye (Lond) (2013) 0.75
Glucocorticoid use and risks of ocular hypertension and glaucoma. JAMA (1997) 0.75
Glucocorticoid use and risks of ocular hypertension and glaucoma. JAMA (1997) 0.75
Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics. Ther Clin Risk Manag (2016) 0.75
Curcumin inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway inflammation through modulation of sequential release of inflammatory mediators (TNF-α and TGF-β1) in murine model. Inflammopharmacology (2017) 0.75
Pneumonia Risk in Asthma Patients using Inhaled Corticosteroids: A Quasi-Cohort Study. Br J Clin Pharmacol (2017) 0.75
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management. Spine (Phila Pa 1976) (1995) 7.70
Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA (1997) 6.12
Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA (1998) 4.44
Persistence of use of lipid-lowering medications: a cross-national study. JAMA (1998) 4.15
Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol (1993) 4.13
A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med (2001) 3.86
Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med (2000) 3.31
Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med (2001) 2.85
Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors. CMAJ (1999) 2.79
Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med (2001) 2.68
Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) (2007) 2.55
Mortality among street youth. Lancet (1998) 2.32
A population-based, randomized clinical trial on back pain management. Spine (Phila Pa 1976) (1997) 2.30
Does home visiting prevent childhood injury? A systematic review of randomised controlled trials. BMJ (1996) 2.27
Hormone replacement therapy use and variations in the risk of breast cancer. BJOG (2008) 2.24
Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis (1986) 2.24
Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ (1996) 2.20
Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis (1988) 2.15
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med (1994) 2.11
The risks and costs of multiple-generic substitution of topiramate. Neurology (2009) 2.07
Measures of effect based on the sufficient causes model. 1. Risks and rates of disease associated with a single causative agent. Epidemiology (1993) 2.06
The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA (1992) 1.98
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax (1998) 1.90
Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer (1999) 1.85
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax (2007) 1.81
Prevalence of HIV infection and risk behaviours among Montreal street youth. Int J STD AIDS (2000) 1.79
Screening for prostate cancer: estimating the magnitude of overdetection. CMAJ (1998) 1.77
Double blind randomized clinical trial examining the efficacy of bupivacaine suprascapular nerve blocks in frozen shoulder. J Rheumatol (2000) 1.73
Predicting arterial oxygenation during one-lung anaesthesia. Can J Anaesth (1992) 1.66
Evaluation of the efficacy of simulation games in traffic safety education of kindergarten children. Am J Public Health (1989) 1.66
Confounding by indication and channeling over time: the risks of beta 2-agonists. Am J Epidemiol (1996) 1.65
The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics (1998) 1.60
Importance and economic burden of occupational back pain: a study of 2,500 cases representative of Quebec. J Occup Med (1987) 1.55
Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J (2005) 1.53
Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. Q J Med (1991) 1.52
Lung function decline in COPD trials: bias from regression to the mean. Eur Respir J (2008) 1.49
Risk factors for hepatitis C virus infection among street youths. CMAJ (2001) 1.48
High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer (1997) 1.46
Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf (2007) 1.44
Population preventable fraction of bicycle related head injuries. Inj Prev (2001) 1.40
Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer (2000) 1.39
Comparison of efficacy and cost among lipid-lowering agents in patients with primary hypercholesterolemia. Can J Cardiol (1998) 1.39
Smoking, treatment for Hodgkin's disease, and subsequent lung cancer risk. J Natl Cancer Inst (1995) 1.39
Exacerbations and intent-to-treat analyses in randomised trials. Eur Respir J (2008) 1.39
Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab (2008) 1.37
Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis (2008) 1.34
Inhaled corticosteroids in COPD: the case against. Eur Respir J (2009) 1.33
Hepatitis B virus infection among street youths in Montreal. CMAJ (1999) 1.32
The effect of socio-demographic and crash-related factors on the prognosis of whiplash. J Clin Epidemiol (1998) 1.31
Usefulness of probucol in treating primary hypercholesterolemia. Can Med Assoc J (1980) 1.27
Falls among the elderly: distinguishing indoor and outdoor risk factors in Canada. J Epidemiol Community Health (1994) 1.23
Risk of recurrence of occupational back pain over three year follow up. Br J Ind Med (1988) 1.22
Predictors of long-term persistence on statins in a subsidized clinical population. Value Health (2006) 1.22
Respiratory health of a population living downwind from natural gas refineries. Am Rev Respir Dis (1989) 1.22
Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA (1993) 1.21
Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertension. Arch Intern Med (2001) 1.21
Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.20
Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J (2006) 1.20
Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies. Hum Reprod (2004) 1.20
Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics (1999) 1.18
The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis (1989) 1.17
Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet (1997) 1.17
Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med (1977) 1.16
Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia. Arch Intern Med (1977) 1.14
Working disability due to occupational back pain: three-year follow-up of 2,300 compensated workers in Quebec. J Occup Med (1988) 1.14
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment. Ann Rheum Dis (2008) 1.12
Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study. Clin Invest Med (2001) 1.12
Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J (2008) 1.11
Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med (1998) 1.10
Concern on quality-of-life analysis in the OPTIMAL study. Ann Oncol (2013) 1.07
Predictors of persistence of use of the novel antidiabetic agent acarbose. Arch Intern Med (2001) 1.05
Spouse similarity for psychological distress and well-being: a population study. Psychol Med (1994) 1.05
End of New Zealand asthma epidemic. Lancet (1995) 1.05
External comparisons with the case-cohort design. Am J Epidemiol (1987) 1.05
Shanghai trial of nifedipine in the elderly (STONE). J Hypertens (1996) 1.04
The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study. Ann Rheum Dis (2011) 1.04
Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction. CMAJ (2001) 1.04
Differences in persistence among different weekly oral bisphosphonate medications. Osteoporos Int (2008) 1.02
Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis Rheum (2005) 1.02
Injection drug use among street youth: a dynamic process. Can J Public Health (1998) 1.02
Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population. Arthritis Rheum (2000) 1.01
Controlling confounding when studying large pharmacoepidemiologic databases: a case study of the two-stage sampling design. Epidemiology (1998) 0.98
Back school in a first episode of compensated acute low back pain: a clinical trial to assess efficacy and prevent relapse. Arch Phys Med Rehabil (1996) 0.96
Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ (1997) 0.96
Autoinhibition in rabbit aortic strips after epinephrine. J Pharmacol Exp Ther (1967) 0.95